Background. Severity scores are useful to guarantee similar disease severity among groups in clinical trials and to enable comparison between different studies. The aim of this study was to assess the performance of the third generation models of severity scoring systems [simplified acute physiology score (SAPS) 3, acute physiology and chronic health evaluation (APACHE) IV and mortality probability model (MPM)-III] in acute kidney injury (AKI) patients in the intensive care unit (ICU). Methods. Three hundred and sixty-six consecutive AKI critically ill patients were prospectively assessed in six ICUs of an academic tertiary care center. Scores were applied on AKI diagnosis day (DD) and on the day of nephrology consultation (NCD). Discrimination was assessed by area under the receiver operating characteristic curve (AUCROC) and calibration by Hosmer-Lemeshow (HL) goodness-of-fit test. Results. Hospital mortality rate was 67.8%. SAPS 3 general and Central and South America (CSA) customized equations presented identical good discrimination (AUCROC curve: 0.80 on NCD) and satisfactory HL tests on both analyzed days (P > 0.100). CSA SAPS 3 equation predicted mortality more accurately [standardized mortality ratio (SMR) on NCD ¼ 1.00 (95% confidence interval (CI) 0.84-1.34)]. APACHE IV and MPM-III scores presented similar discrimination compared to SAPS 3 on both analyzed days (P > 0.05). APACHE IV presented satisfactory HL tests over time (P > 0.100) but underestimated mortality [SMR on DD ¼ 
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Introduction
One of the main problems concerning the design of clinical trials in critically ill acute kidney injury (AKI) patients is the lack of validated, well-established scoring systems to stratify the severity of patient disease states and guarantee adequate randomization within a particular study design [1, 2] . It remains unsettled, which are the best models (general or specific scores) for AKI patients and the most appropriate moment for scores application. Also, most studies reported thus far have been limited by small sample sizes and the absence of a uniform AKI definition. Patients in different stages of AKI and diverse severity have been compared, contributing to the discrepancies in the performance of these models. Nevertheless, we have previously demonstrated that simplified acute physiology score (SAPS) II and Stuivenberg Hospital Acute Renal Failure scores presented the best performance in critically ill AKI patients. [3] [4] [5] [6] [7] [8] [9] .
The RIFLE system [10] , now validated in >71 000 patients worldwide, included patients in the early phases of AKI and provided a simple and universal AKI definition, allowing comparisons among studies [11] [12] [13] [14] . The RIFLE classification of severity staging also proved to be associated with mortality, becoming the most powerful prognostic AKI stratification system validated so far [14] . However, there are still scant data concerning the assessment of illness severity scores in AKI patients using the RIFLE system. General intensive care unit (ICU) models usually underestimate the mortality of AKI patients. Most studies have assessed the second generation scores [acute physiology and chronic health evaluation (APACHE) II [15] and APACHE III [16] , SAPS II [17] , Sepsis-related organ failure assessment [18] , Logistic organ dysfunction system [19] ], which were developed in the mid 1990s [20] . The recent third generation of ICU scoring systems [SAPS 3 [21] , APACHE IV [22] and mortality probability model (MPM) III [23] ] are powerful and updated models. Although they were assessed in several groups of ICU patients [24] [25] [26] [27] [28] [29] [30] , these models have never been evaluated in non-dialysis AKI patients.
The aim of this study was to evaluate the performance of the third generation of severity scoring systems (APACHE IV, SAPS 3 and MPM-III) in a group of critically ill patients with AKI defined according to the RIFLE system criteria.
Patients and methods

Study participants
A prospective observational study was conducted through an active search for AKI cases by daily visits to six ICUs comprising 53 beds, in the Hospital das Clinicas of University of Sao Paulo School of Medicine, Brazil. This is a tertiary academic hospital with 13 ICUs and 128 available beds for critically ill patients; only general clinical and surgical ICUs were chosen. All specific ICUs were excluded, such as cardiac surgery, coronary, bone marrow, solid organ transplantation and pediatric ICUs.
All patients admitted to the selected ICUs were evaluated for renal function in the period between November 2003 and June 2005. AKI was defined as an increase of !50% of the baseline serum creatinine (SCr) measurement according to the R (risk) level criteria of the RIFLE system. Baseline SCr was defined as the lowest value obtained during the hospital stay or within 30 days before diagnosis. The exclusion criteria included baseline SCr !3.0 mg/dL, previous dialysis, age <18 years, kidney transplantation, an ICU stay shorter than 48 h, urinary tract obstruction and hypovolemia responsive to fluids. Vital signs and hemodynamic and laboratory data were recorded on AKI diagnosis day (DD) and on the day of nephrology consultation (NCD). Severity scores (APACHE IV, SAPS 3 and MPM III) were calculated longitudinally considering the worst value of physiologic variables measured every 24 h. Scoring elements are described in Table 1 . A complete description of inclusion and exclusion criteria, data elements, data collection, organ failure and related parameters and management strategies have been previously detailed [9] . Data were collected by an independent single observer, non-member of the ICU or nephrology staff. Nephrology consultation (NC) was solicited by the ICU physician. The primary outcome was in-hospital mortality. The study was approved by the local Ethics Committee and informed consent was not required.
Statistical analysis
All 366 patients were sequentially evaluated. Continuous variables were expressed as mean AE SD or as median with 25th and 75th quartiles as appropriate. Categorical variables were expressed as proportions and analyzed with Pearson's v 2 test for independent groups. Logistic regression was employed to determine the adjusted odds of in-hospital mortality. Two models were built using variables of each analyzed day. Candidate variables were those with a likelihood ratio significance <0.05 upon bivariate analysis. Multivariable logistic regression models were constructed with backwards variable selection, using a P-value <0.05 for variable retention. The colinearity of the maximal models was evaluated using the criteria proposed by Belsley [31] . Discrimination was assessed using the area under the receiver operating characteristic curve (AUCROC) [32] . Calibration was assessed using the Hosmer-Lemeshow (HL) goodness-of-fit test comparing observed versus expected mortality across deciles of risk [33] . A high P-value (>0.05) indicated a good fit of the model. The standardized mortality ratio (SMR) with respective 95% confidence intervals (CIs) was calculated for each model by dividing the observed by the predicted mortality rate. AUROCs were compared using nonparametric statistics [34] . A two-tailed P-value <0.05 was considered significant. Statistical analysis was carried out using SPSS for Windows version 18.0 (Chicago, IL) and SAS (SAS Institute, Cary, NC).
Results
A total of 2998 patients were admitted to the selected ICUs during the study period. The final sample size comprised 366 AKI patients ( Figure 1 ). Mean age was 57.1 AE 18.8 and main AKI-related factors were sepsis (67%) and surgery (22.1%). Patients' origin before ICU admission were emergency room (40.4%), ward (32.8%) and operating room (23.5%). Median hospital length of stay (LOS) before ICU admission was 4.0 (1.0-11) days and AKI diagnosis occurred within the first 2 days after ICU admission in 64% of patients. One hundred and twelve patients (30.6%) required dialysis therapy and overall hospital mortality was 67.8% (Table 2 ). NC occurred 3 days (1.0-4.0) after DD. Main physiological and laboratory variables on both days are presented in Table 3 . Additional prognostic factors were determined by multivariate analysis. Advanced age, lower urine output, longer LOS in the ICU (before AKI diagnosis) and central nervous system (CNS) failure were included in the logistic regression models for mortality on both days of analysis (Table 5) . On DD, low albumin and low SCr concentrations, cardiovascular and liver failures were also related to higher mortality. In addition, the AUCROC for death was 0.84. On NCD, the following variables were also related to increased mortality: higher lactate values, respiratory and liver failure. Mortality model discrimination was good, with an AUCROC of 0.88, higher than those obtained on the preceding day (P < 0.05). Models presented good sustained calibration over time (P ¼ 0.50 and P ¼ 0.85, on DD and NCD, respectively).
Discussion
The third generation models of ICU prognostic systems are more complex than their previous counterparts. They have been developed based on larger databases and built using more complex statistical modeling techniques. ICU admission causes were expanded and refined and new important prognostic factors like patient origin, infection site and hospital LOS were included [35, 36] . SAPS 3 score, the last version of the SAPS system published in 2005, was the largest prospective multinational study conducted so far, with enrollment of 19 577 patients in 307 ICUs from 35 countries of the five continents between October and December 2002. The main differences compared with SAPS II are data collection on AE1 h from ICU admission and derivation of seven customized equations for different geographic regions.
In this study, the SAPS 3 GEq and customized CSA equation generated nearly the same prediction despite being mathematically different, resulting in identical observed AUCROC on both analyzed days. The SAPS 3 calibration HL tests (for GEq and CSA equations) were satisfactory on both assessed days and SAPS 3 customized equation for CSA countries presented the best SMR, reflecting the impact of important geographical differences such as patients' living styles and presence of comorbidities and health care systems. SAPS 3 was the most frequently assessed score among the third generation models with several studies demonstrating good discrimination (AUCROC > 0.80) [24, 26, [28] [29] [30] . Calibration difficulties were more frequently observed [24, 26, 28] . However, three prospective studies, including the Maccariello et al. [8] , in which they have assessed a group of 244 AKI dialysis patients, presented similar results: adequate calibration and accurate prediction from CSA-customized equation [29, 30] . In our study, SAPS 3 discrimination was good on NCD [(AUCROC: 0.80 (95% CI 0.73-0.86)], while it was regular on DD [AUCROC: 0.73 (95% CI 0.67-0.79)]. Physiological variables were collected in a 24 h window, which may have influenced model discrimination. Indeed, AKI may not be detected within the short time frame of 1 h. Limiting data collection to the first hour of ICU admission was proposed to avoid the influence of the ICU-delivered care. Results expressed as mean 6 SD, median (25th-75th) and n (%).
Nevertheless, in centers with shortage of ICU beds, under treatment during long pre-ICUs stays (our median time was 4.0 days) could actually overestimate mortality in the ICU admission, which could be partially corrected over the following 24 h with appropriate medical care. It is not clear how this change could influence the model's accuracy. Another aspect that may have influenced score's discrimination is the SAPS 3 kidney dysfunction evaluation, which is based exclusively on proposed SCr values (SCr mg/dL stratification: <1.2, 1.2-2.0, 2.1-3.4, !3.5). APACHE IV, the last version of APACHE score system, published in 2006, was prospectively developed in 131 988 patients admitted to 104 ICUs in USA, providing predictions of hospital mortality and ICU LOS. APACHE IV has never been evaluated for AKI patients. In our study, this model presented similar discrimination and satisfactory HL tests as compared to SAPS 3. The satisfactory accuracy of APACHE IV is probably explained by the large number of physiological variables, including serum albumin level, a more refined CNS impairment assessment and multiple use of SCr, serum urea level (Sur) and diuresis for kidney function evaluation. Also, the large number of ICU diagnosis admissions (116 detailed options which accounted for 16% of model explanatory power) improved disease identification and calibration. In our study, APACHE IV underestimated mortality, probably due to important differences from the original database: higher mortality rate (13.5 versus 67.8 %), sepsis etiology (5.4 versus 66.7 %) and longer pre-ICU LOS (0.78 versus 4.0 days). Despite commonly shared features, APACHE IV and SAPS 3 have some differences: origin (American versus multinational nature), acute physiologic variable explanatory power (66 versus 25%, respectively), data collection window (24 versus 1 h) and kidney dysfunction parameters. Since these two models have never been compared in a large sample of AKI ICU patients, it remains to be defined which score would be more adequate for these patients. MPM-III presented the worst performance among the third generation models with satisfactory discrimination but inadequate calibration, and the observed mortality was double compared with the predicted mortality. MPM-III model presented satisfactory performance in a retrospective study of 11 300 general ICU patients [25] . However, two recent prospective studies reported mortality underestimation: Soares et al. [30] have assessed a group of 717 critically ill cancer patients with an SMR: 3.42 (95% CI 2.63-4.41) and Maccariello et al. [8] found a SMR: 2.42 (95% CI 1.95-3.01) assessing dialysis AKI patients.
MPM-III score was developed in a large sample of 124 855 patients admitted to 135 ICUs, mostly in the USA. However, the model has several limitations, including retrospective data collection nature and inclusion of a limited number of variables: age, three physiologic parameters (coma, heart rate and systolic blood pressure), five acute and three chronic diagnosis and a few other parameters (cardiopulmonary resuscitation, mechanical ventilation and admission type). ICU entry diagnosis was not included and AKI was defined only by SCr values (>2.0 mg/dL). In addition, data collection window is also 1 h, leading to the same methodological problems for AKI patients as discussed for SAPS 3.
Logistic models provided further data on outcome prognosis. Low serum albumin levels have been associated with worse prognosis in both general critically ill and AKI patients, probably reflecting the intense inflammatory and hypercatabolic AKI status [37] . However, only APACHE IV includes albumin levels among the assessed variables which should be evaluated in future models. Increased lactate level has been reported as a single prognostic factor in ICU patients, presenting similar discrimination compared with most prognostic scores in the BEST study [20] . Interestingly, no severity scoring system has included lactate level among assessed parameters. Increased ICU LOS before AKI diagnosis has been implicated as a very important prognostic factor in recent studies, usually related to more serious events, such as infection [38] . Association between lower SCr and increased mortality was previously described, which could be explained by factors such as diminished muscle mass, malnutrition and fluid overload [39] [40] [41] . This is an important observation since all ICU scores stratify AKI severity according to specific criteria, usually attributing higher severity to increased SCr levels. Currently, there is no scoring system that applies SCr stratification as proposed by the RIFLE or AKIN systems [42] . Furthermore, some models utilize Sur (or blood urea nitrogen), which is more susceptible to several influences.
The strengths of this study rely on the prospective nature, with an active search for new AKI cases in a large sample of critically ill patients. For the first time, the performance of the new third generation scores was assessed in a sample of non-dialysis AKI patients using the RIFLE system criteria. Use of a less severe AKI definition allowed evaluation from early stages of the disease, improving model performance. In addition, only 8.5% of the sample was excluded, minimizing the risk of selection and analysis bias. Additionally, data were collected by one single investigator, minimizing the interobserver effect. Despite the presence of the investigator, she had no contact with ICU physicians on duty and simply collected the data. Thus, there was no influence on the ICU staff decision for NC.
Although almost four hundred patients were included in this study, severity score validation is better assessed in larger samples [43] . The main limitation refers to the modification of SAPS 3 and MPM-III original methodology. Considering this study as the first report with non-dialysis AKI patients, we could not compare our results. Also, general ICU models were developed to be applied on ICU admission day and observed mortality underestimation might have been influenced by the latter application [44] . Furthermore, we could not exclude a possible casemix influence as well as local differences in the delivered care, ICU infrastructure and patient referral [45] . The long pre-ICU LOS was an important factor, which may have influenced models performance. Finally, we had a homogeneous population, which may be difficult to reproduce elsewhere.
Conclusions
In this prospective study, the customized equation of SAPS 3 from CSA countries was the most accurate scoring system among the third generation models for prediction of hospital mortality in AKI critically ill patients. APACHE IV score presented satisfactory performance but underestimated mortality. These results represent an important step forward for the validation of prognostic models, which are essential for the development of clinical trials with AKI critically ill patients.
